Related Experiment Video

Updated: Sep 30, 2025

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K

Utilization of macrolides. State of the art 2022 Spilf and GPIP

J P Stahl1, B Castan2, E Bonnet3

  • 1Infectiologie, Université Grenoble Alpes, 38700, La Tronche, France.

Infectious Diseases Now
|March 11, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

Related Experiment Videos

Last Updated: Sep 30, 2025

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

248
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
248
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

437
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
437

Articles linked to this work by shared authors, journal, and citation graph.

18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.

Breast cancer research : BCR·2025

Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Study of the Beta Spectrum Shape of ^{92}Rb and ^{142}Cs Decays for the Prediction of Reactor Antineutrino Spectra.

Physical review letters·2025

Dalbavancin for prosthetic joint infections: Empirical treatment.

Infectious diseases now·2025

Breaking bad news: an active learning method for medical students.

BMC medical education·2024

Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) - 2023 SPILF.

Infectious diseases now·2023

Low-dose amoxicillin as prophylaxis for recurrent erysipelas: Is it the answer?

Infectious diseases now·2026

Impact of pneumococcal conjugate vaccines on S. pneumoniae carriage in infant and toddlers with acute otitis media in Morocco.

Infectious diseases now·2026

Climate-sensitive infectious diseases in the context of climate change: Lessons from Brazil's floods, with leptospirosis as an example.

Infectious diseases now·2026

The role of corticosteroids in management of non-HIV immunocompromised patients hospitalized for Pneumocystis jirovecii pneumonia.

Infectious diseases now·2026

Seroprevalence of hepatitis E virus infection among pregnant women in South Africa at time of delivery.

Infectious diseases now·2026

Evaluation of Xpert MTB/RIF Ultra, BD MAX MDR-TB and Anyplex MTB/NTM vs. MGIT/MALDI-TOF in mycobacterial diagnosis.

Infectious diseases now·2026

To scramble or not: Steric blocking 2'-MOE/PS control antisense oligonucleotides across cellular models.

Molecular therapy. Nucleic acids·2026

Evaluation of the usability, efficacy and safety of a novel ophthalmic eye drop dispenser designed to deliver preservative-free artificial tears for the treatment of dry eye disease.

Therapeutic advances in ophthalmology·2026

Preparation of Highly Functionalized ortho-Naphthoquinone Methides and Their Subsequent Intermolecular [4 + 2]-Cycloadditions with Olefins.

Chemical & pharmaceutical bulletin·2026

Janus amphiphilic organization as a shared structural basis for antifreeze and antimicrobial functions in short α-helical peptides.

Colloids and surfaces. B, Biointerfaces·2026

Chemical components with antitumour activity from Inula britannica.

Phytochemistry·2026

Diallyl sulfide pretreatment protects against DSS-induced colitis by reshaping the gut microbiota and enhancing microbiota-associated tryptophan metabolism.

Journal of ethnopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us